SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Guidant (GDT)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
235 17 0 GDT
Emcee:  Todd King Type:  Unmoderated
Introduction Market Data Compact
Is anyone out there following Guidant Corp? I have held this issue since it was spun off from Eli Lilly in August 1995. Guidant makes medical products such as pacemakers, stents, etc. Major competitors are Medtronic, St. Jude Medical and J&J.

The company appears to be well managed, and uses EVA to help ensure capital employed increases shareholder value. A recent report in Barron's (11/30/96) suggested that new products to be introduced in 1997 should fuel continued earnings growth.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
235Boston Closes Guidant Deal thestreet.com A very nice return all-n-all... Good Allegoria-4/24/2006
234Boston Scientific delays Guidant deal close MAR. 1 8:40 P.M. ET Boston ScientifAllegoria-3/2/2006
233Let's lay out the facts as they stand today. As some have suggested, this Allegoria-2/16/2006
232Reuters Merger talk to overshadow Boston Scientific results Monday February 6, 4Allegoria-2/16/2006
231Yes, I understand that. But what is odd is that GDT is trading just at $75 for X-Ray Man-2/13/2006
230It is possible the price of GDT will go back up with approval, but I don't tLance Bredvold-2/13/2006
229Well, I guess the most recent announcements from BSX in terms of moving forward X-Ray Man-2/7/2006
228I suspect the reason the price of GDT rides below BSX's offer is that much Lance Bredvold-2/5/2006
227I can't understand why noone has posted since 2003, considering all of the tX-Ray Man-1/30/2006
226i can't understand why it isn't getting killed over this issue.Dennis-6/17/2003
225Glenn, GDT is up since its nadir several months ago, but I think management reaAusdauer-6/13/2003
224<b>Guidant Admits That It Hid Problems of Artery Tool</b> June 13, Glenn Petersen-6/13/2003
223Mike, I think the projections can be made based on existing patients... ...whicAusdauer-1/15/2003
222Dennis, Not sure why the previous link did not work. I am posting the same areMike-1/14/2003
221found this site through Mike at mdt.... mapdigital.com. hope it helps good luDennis-1/14/2003
220Jonathan, I am not sure there has been a run-up in the true sense. The bottom Ausdauer-1/14/2003
219Given recent run up in Guidant, do you see it as a good time to cut the bait andjonathan romanowsky-1/14/2003
218<b>http://www.theheart.org</b> "Failing to DELIVER" <Ausdauer-1/3/2003
217<b>Guidant torpedoes Cook.</b> Has anyone read this? guidant.com Ausdauer-1/3/2003
216Guidant is stentless for the present time... ...with respect to a drug eluting Ausdauer-1/2/2003
215IN THE PIPELINE: Pacemaker Could Be Key To Getting Zzz's By DANIEL ROSENBERLance Bredvold-12/5/2002
214I hate to say "I told you so"... ...and I don't have any grudge aAusdauer-11/27/2002
213<i>"GDT is making a big investment in Cook in order to try to level tAusdauer-10/2/2002
212Please remember to take a pause of silence on September 11th for the loved lost Art Baeckel-9/6/2002
211Lighthouse, I imagine BSX has spent a ton on clinical research to date. If theiAusdauer-9/4/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News